Meningioma

Longitudinal Prospective Study of Neurocognition & Neuroimaging in Primary BT Patients

Study in Children and Adolescents of 177Lu-DOTATATE (Lutathera®) Combined With the PARP Inhibitor Olaparib for the Treatment of Recurrent or Relapsed Solid Tumours Expressing Somatostatin Receptor (SSTR) (LuPARPed).

A Study of Zanzalintinib in Participants With Recurrent or Progressive Meningioma

Cognitive Status After Removal of Skull Base Meningioma

Analysis of Cerebrospinal Fluid Leakage After Surgery for Intracranial Tumors

Long-Term Longitudinal QoL in Patients Undergoing EEA

Comparison of Skin Closure Techniques in Oncological Neurosurgical Procedures: Intradermal Running Suture Versus Transdermal Interrupted Sutures

Tumor Genomics, Individual Risk Factors, and External Drivers of Health on Health Outcomes for Patients With Meningioma

Adjuvant Hypofractionated Stereotactic Radiosurgery for Intermediate-risk Meningioma

Gleolan for Visualization of Newly Diagnosed or Recurrent Meningioma

Cabozantinib for Patients With Recurrent or Progressive Meningioma

Targeted Alpha-Particle Therapy for Advanced Somatostatin Receptor Type 2 (SSTR2) Positive Tumors

DOTATOC PET/CT for Imaging NET Patients

A Study of the Boron Neutron Capture Therapy (BNCT) Using B10 L-BPA in Recurrent Meningioma

Innovative Trial for Understanding the Impact of Targeted Therapies in NF2-Related Schwannomatosis (INTUITT-NF2)

Pharmacoscopy for Patients With Refractory Primary Brain Tumors

Research of Biomarkers of Response to Proton Beam Therapy in Pediatric and Adult Patients.

A Study of JZP3507 (ONC206) in Recurrent Grade 2 or 3 Meningioma

A Trial of Increased Dose Intensity Modulated Proton Therapy (IMPT) for High-Grade Meningiomas

Lutathera for Treatment of Recurrent or Progressive High-Grade CNS Tumors